Author:
Adjei Alexander,Narh-Bana Solomon,Amu Alberta,Kukula Vida,Nagai Richard Afedi,Owusu-Agyei Seth,Oduro Abraham,Macete Eusebio,Abdulla Salim,Halidou Tinto,Sie Ali,Osei Isaac,Sevene Esperance,Asante Kwaku-Poku,Mulokozi Abdunoor,Compaore Guillaume,Valea Innocent,Adjuik Martin,Baiden Rita,Ogutu Bernhards,Binka Fred,Gyapong Margaret
Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Parasitology
Reference37 articles.
1. WHO. Guidelines for the Treatment of Malaria. 2nd edn. Geneva: World Health Organization; 2010. whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf. Accessed Nov 2014.
2. WHO. World Malaria Report 2014. Geneva: World Health Organization; 2014. http://www.who.int/malaria/…/world_malaria_report_2014/wmr-2014-no-profile . Accessed Dec 2014.
3. Salman S, Page-Sharp M, Griffin S, Kose K, Siba PM, Ilett KF, et al. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria. Antimicrob Agents Chemother. 2011;55:5306–13.
4. Nosten F, White NJ. Artemisinin-based combination treatment of falciparum malaria. Am J Trop Med Hyg. 2007;77:181–92.
5. Tarning J, Ashley EA, Lindegardh N, Stepniewska K, Phaiphun L, Day NP, et al. Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand. Antimicrob Agents Chemother. 2008;52:1052–61.